A Fair Artificial Intelligence Research & Regulation (FAIRR) Bureau
Summary
Artificial intelligence (AI) is transforming our everyday reality, and it has the potential to save or to cost lives. Innovation is advancing at a breakneck pace, with technology developers engaging in de facto policy-setting through their decisions about the use of data and the embedded bias in their algorithms. Policymakers must keep up. Otherwise, by ceding decision-making authority to technology companies, we face the rising threat of becoming a technocracy. Given the potential benefits and threats of AI to US national security, economy, health, and beyond, a comprehensive and independent agency is needed to lead research, anticipate challenges posed by AI, and make policy recommendations in response. The Biden-Harris Administration should create the Fair Artificial Intelligence Research & Regulation (FAIRR) Bureau, which will bring together experts in technology, human behavior, and public policy from all sectors – public, private, nonprofit, and academic – to research and develop policies that enable the United States to leverage AI as a positive force for national security, economic growth, and equity. The FAIRR Bureau will adopt the interdisciplinary, evidence-based approach to AI regulation and policy needed to address this unprecedented challenge.
By structuring licensing-and-talent deals that replicate mergers while avoiding antitrust scrutiny, dominant technology firms are reshaping AI labor markets, venture financing, and the future of U.S. innovation.
It is in the interests of the United States to appropriately protect information that needs to be protected while maintaining our participation in new discoveries to maintain our competitive advantage.
Our analysis of federal AI governance across administrations shows that divergent compliance procedures and uneven institutional capacity challenge the government’s ability to deploy AI in ways that uphold public trust.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.